Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John K. Bakewell currently holds 204,056 shares of TREACE MEDICAL CONCEPTS, INC. (TMCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John K. Bakewell has been a net seller of TMCI stock. They have purchased $594.1K and sold $4.4M worth of shares.
John K. Bakewell's most recent insider trade was on May 19, 2026, when they sold 30,000 shares at $0.00 per share.
John K. Bakewell serves as Executive at TREACE MEDICAL CONCEPTS, INC. (TMCI). They have executed 54 insider transactions totaling $5.0M over their tenure at the company.
John K. Bakewell holds the position of Executive at TREACE MEDICAL CONCEPTS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
John K. Bakewell has shown a selling trading pattern, with $594.1K in total purchases and $4.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John K. Bakewell was on May 10, 2024, when they purchased $594.1K worth of TMCI shares. This transaction involved 130,000 shares at $4.57 per share.
John K. Bakewell currently owns 204,056 shares of TREACE MEDICAL CONCEPTS, INC. (TMCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John K. Bakewell's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John K. Bakewell has 54 Form 4 filings on record as an insider at TREACE MEDICAL CONCEPTS, INC..
Set alerts for John K. Bakewell and 40,000+ other insiders.